Rilmazafone | |
---|---|
Salts [] | |
---|---|
Rilmazafone hydrochloride | |
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 475.3 g/mol [1] |
Predicted LogP | 2.3 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C21H20Cl2N6O3 [1] |
IUPAC name | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide [1] |
SMILES | CN(C)C(=O)C1=NN(C(=N1)CNC(=O)CN)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl [1] |
InChI | InChI=1S/C21H20Cl2N6O3/c1-28(2)21(32)20-26-17(11-25-18(30)10-24)29(27-20)16-8-7-12(22)9-14(16)19(31)13-5-3-4-6-15(13)23/h3-9H,10-11,24H2,1-2H3,(H,25,30) [1] |
InChIKey | KYHFRCPLIGODFH-UHFFFAOYSA-N [1] |
Rilmazafone
Rilmazafone (also known as Rilmazafona, Rilmazafonum, 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride, RefChem:913030, S 450191, S-450191, 5-(((2-Aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide, 99593-25-6 free base), 1H-1,2,4-Triazole-3-carboxamide,5-[[(aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl- or EX-A5707) is a
Chemistry
Salts []
Rilmazafone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Rilmazafone is a achiral mixture
Anodyne Usernotes [] | |
---|---|
magnus / Rilmazafone via Oral | - |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5069, Rilmazafone. Accessed September 1, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5069
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Rilmazafone. UNII: CU3H37T766. Global Substance Registration System. Accessed September 1, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CU3H37T766